Pharmacy - Events

In this two day workshop conference you will learn the requirements and expectations of major health care regulators that are applicable to "virtual" companies. You will learn how to diagnose your company's needs based on which GMP and GCP-governed operations you retain and which you outsource; what the current expectations and best industry practices are for selecting, qualifying and monitoring your contractors to ensure they are meeting your requirements; and how to build a quality system framework that is not excessive for your current needs, but has the structure and integration to "grow with you" as the scope your operations change in the coming months and years. Learning Objectives: Participants in this seminar will: Understand the GMP and GCP requirements all virtual companies must…

Use coupon COMPLIANCE15 to get 15% discount on this virtual seminar This seminar bridges that gap. Designed specifically for non-statisticians, it provides a clear, practical introduction to biostatistics without overwhelming you with mathematics. You’ll learn the “why” behind the numbers, gain tools to spot meaningful findings, and avoid being misled by misused statistics. By the end of the program, you’ll be able to read statistical reports with confidence, communicate findings to colleagues and stakeholders, and make better data-driven decisions that can shape the future of clinical and biotech innovation. Why Should You Attend: In the world of clinical research and biotechnology, numbers carry weight. A single statistical finding can influence whether a project moves forward, a regulat…

Use coupon COMPLIANCE15 to get 15% discount on this virtual seminar Sterile products may be broadly classified into two main categories based on their production mode -- those that are terminally sterilized following the filling and sealing of the container and those that are aseptically sterilized, that is, filter sterilized as a bulk product, filled, and then sealed. Aseptic Processing play a critical role with large molecules that cannot be terminally sterilized. The verification of the process to produce sterile product is evaluated through the demonstration of various media fill process simulations that will vary in both numbers and size of the containers as well as the volumes filled over a defined period.  Aseptic Processing involves risk assessment on an on-going basis because…

This program combines general considerations for Good Manufacturing Practice (GMP) compliance management with the principles of phase-appropriate GMP considerations, with an emphasis on needs of virtual companies. (“Virtual companies” are those who outsource GMP operations to Contract Manufacturing Organizations (CMOs) and Contract Analytical Laboratories.) Virtual companies typically do not conduct “hands on” manufacturing, but do perform tasks which are governed by GMP, for example, dispositioning final product, managing the supply chain, investigating complaints, and providing training to staff in GMP compliance concepts. Such companies often struggle to decide how to structure their quality management system, which procedures they need or do not need, and how to best manage vendor rela…

SAE Media Group's AI in Drug Discovery 2026 takes place 9–10 March in London. Join pharma and biotech leaders to explore how AI, ML, and generative tools are transforming drug pipelines. The agenda features case studies, clinical updates, and expert panels on target ID, computational design, and scaling AI across R and D. Discover the latest breakthroughs and connect with directors and heads of informatics, molecular design, and data science.   Date and Time: On Monday March 09, 2026 at 8:30 am to Tuesday March 10, 2026 at 6:00 pm Venue details: Hilton London Kensington, 179-199 Holland Park Avenue, London, England, W11 4UL, United Kingdom

The marcus evans S&OP and IBP for Pharma & Life Science conference taking place on 23-25 March, 2026, in Frankfurt, Germany, will bring together senior leaders in supply chain, finance, and planning to explore how pharmaceutical and life sciences organizations are transforming S&OP/IBP to accelerate decision-making, enhance planning accuracy, and strengthen business alignment. Key Topics Include:  Transform S&OP into IBP to Connect Strategy, Finance, and Execution Cross Functional Collaboration – Key for Successful S&OP/IBP Balance Short- and Long-Term Planning to Enable Strategic Alignment Leverage AI and Data to Strengthen S&OP and IBP Foundations Drive Change Management to Advance S&OP and IBP Maturity Align Portfolio and Demand to Build a Single Planni…

CMAC Open Days 2026: Join us 24–26 March 2026 as we celebrate 15 years of CMAC transforming medicines manufacturing. Discover how Industry 5.0 technologies are shaping the future of medicines manufacturing, with insights into the latest trends, tools, and strategies for creating future-ready, resilient and sustainable manufacturing processes. At the Open Days you’ll: 🤝 Network with top academics, industry leaders, and researchers 👩‍🔬 Engage in interactive sessions, lab tours, and poster presentations 💊 Learn about the latest innovations tackling real-world pharmaceutical challenges 🎟️ Registration is now open! Take advantage of early bird rates available until Monday 2 February 2026: £100 standard (rising to £125 after early bird) £80 PhD student (rising to £90 after early bird)

Europe's oligonucleotide landscape is entering a pivotal growth phase. With the €21M launch of Aerska and major collaborations such as Novartis and SciNeuron, Lundbeck and Contera, and Secarna and Vect-Horus, European biopharma are rapidly advancing RNA-targeted approaches to address previously undruggable CNS diseases.  In response to this momentum, the inaugural Oligonucleotides for CNS Summit Europe will unite 60+ senior industry leaders for the first European forum dedicated exclusively to CNS-focused Oligonucleotide therapeutics.  The summit delivers three days of highly technical, data-driven discussions addressing the challenges unique to CNS development with insight into next-generation BBB delivery strategies beyond TfR1, advanced in vivo and iPSC models, novel chemistry…

The Marcus Evans 17th Edition Strategic Alliance Management for Pharma conference taking place in Barcelona, Spain on 21-23 April, 2026, will explore how to build resilient partnerships that deliver measurable value, leveraging both human and AI-driven capabilities. It will bring together leading pharma and biotech companies to discuss how alliances are evolving across the full partnership lifecycle - from deal negotiation to execution, governance, and value creation. It wll focus as well on the rapidly evolving environment shaped by AI adoption, global market shifts, cultural dynamics, and new partnership models. Attending this premier Marcus Evans conference will enable you to: Establish Effective Governance and Decision-making Process within the Alliance Navigating Data Management from…

The Marcus Evans 17th Edition Strategic Alliance Management for Pharma conference taking place in Barcelona, Spain on 21-23 April, 2026, will explore how to build resilient partnerships that deliver measurable value, leveraging both human and AI-driven capabilities. It will bring together leading pharma and biotech companies to discuss how alliances are evolving across the full partnership lifecycle - from deal negotiation to execution, governance, and value creation. It wll focus as well on the rapidly evolving environment shaped by AI adoption, global market shifts, cultural dynamics, and new partnership models. Attending this premier Marcus Evans conference will enable you to: Establish Effective Governance and Decision-making Process within the Alliance Navigating Data Management from…

The Pharma Partnering Summit is an exclusive Life Sciences Industry event, with the aim to help companies expand their network and put together licensing deals, research collaborations and financing. Our platform brings together senior executives from different parts of the world specialising in Business Development & Licensing, Alliance Management, Research Collaborations, M&A and Investment. In addition to identifying products and partners as well as investors, the forum also serves to disseminate knowledge through expert speakers, for the best practices in the field of industry partnerships.  

The Pharma Partnering Summit is an exclusive Life Sciences Industry event, with the aim to help companies expand their network and put together licensing deals, research collaborations and financing. Our platform brings together senior executives from different parts of the world specialising in Business Development & Licensing, Alliance Management, Research Collaborations, M&A and Investment. In addition to identifying products and partners as well as investors, the forum also serves to disseminate knowledge through expert speakers, for the best practices in the field of industry partnerships.  

The UK Biotech Day is a leading event for the UK life sciences sector, bringing together executives and R&D scientists from pharma, biotech, medtech, techbio, investors, lawyers, patent attorneys, CROs, CDMOs, accountants, bankers, executive search agencies and others. Serving as a global gateway, it also connects the UK ecosystem with international partners to drive strategic collaborations through dealmaking, innovation, networking and finding new clients and partners.

Foster Innovation and Collaboration at the 10th Annual Pre-Filled Syringes and Injectable Drug Devices West Coast Conference! Join us in June 2026 as SAE Media Group's renowned West Coast event returns, bringing together biotech pioneers, pharma leaders, and device innovators to shape the future of injectable drug delivery. This year's conference will bring a brand NEW focus day followed by the two-day main conference offering an unparalleled platform to explore cutting-edge advances in combination product technology while fostering collaboration between pharma, device developers, and regulators. What You'll Gain: Actionable insights to strengthen your drug-device portfolio.Opportunities to network with key players shaping the injectable drug delivery landscape.A future-focused perspective…

EuroQSAR Symposia are taking place since 1973 and constitute major scientific events in the field of computational drug design, with further applications in agricultural and environmental sciences.The 24th EuroQSAR Symposium,  entitled "Synergizing AI and Multiscale Modeling for Drug Discovery", is organised on behalf of QCMS and is chaired by Jordi Mestres (University of Girona). The symposium will focus on: Computational Design of Covalent Drugs Free Energy and Kinetics of Drug-target Binding Omics Science in Drug Discovery Artificial Intelligence and Statistical Learning in Drug Discovery QSAR and Machine Learning for DM/PK In silico/in vitro Models for Drug Safety Virtual Screening Successful Stories Next-generation Docking: Focus on Conformational Entrop…